Prevalence of Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Associated Clinical Implications at the University Teaching Hospital of Kigali in Rwanda
The American Journal of Tropical Medicine and Hygiene · 2024
DOI: 10.4269/ajtmh.23-0605 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2024. Verfasst von Muhirwa Patrick Kayinamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Teaching Hospital of Kigali, Kigali, Rwanda. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Klebsiella pneumoniae, Enterobacteriaceae Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae poses a global problem and complicates therapeutic choices. The paucity of data in resource-poor countries undermines the understanding of the problem’s extent, and cases of antimicrobial treatment failure continue to accumulate. This study aimed to determine the prevalence and clinical implications of ESBL-producers at the University Teaching Hospital of Kigali in Rwanda. A 1-year cross-sectional retrospective study was conducted on Escherichia coli and Klebsiella pneumoniae isolated in blood and urine from January 1 to December 31, 2022. In total, 1,283 isolates were recorded. The results showed an overall prevalence of ESBL phenotypes at 300/1,283 (23.4%). Extended spectrum beta-lactamase–positive E. coli was more frequently detected than K. pneumoniae in both urine (20.6% versus 10.1%) and blood (8.8% versus 6.2%). These isolates were 100% resistant to amoxicillin-clavulanic acid, third-generation cephalosporins, piperacillin, sulbactam ampicillin, ampicillin, cefuroxime, and cefoxitin. The least resistance was observed to amikacin (18%), meropenem (10%), and polymyxin B (3%). Hospital stays ranging from 8 to 21 days were the most frequent, and the mortality rate was 10.3% in patients with ESBL cases, which was more than double the general hospital mortality rate in the same period. In conclusion, our findings indicate a high prevalence of ESBL phenotypes, high antibiotic resistance rates, prolonged hospital stays, and an increased mortality rate. These findings suggest the need for continued surveillance, planning appropriate interventions, and caution during empirical therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Teaching Hospital of Kigali, Kigali, Rwanda.
- School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Zitieren
APA
Kayinamura, M. P., Muhirwa, A., Kamaliza, A. C., Bigirimana, Y., Rutare, S., Hahirwa, I., Nkubana, T., Dusabe, A., & Munyemana, J. B. (2024). Prevalence of Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Associated Clinical Implications at the University Teaching Hospital of Kigali in Rwanda. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.23-0605
Vancouver
Kayinamura MP, Muhirwa A, Kamaliza AC, Bigirimana Y, Rutare S, Hahirwa I, et al. Prevalence of Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Associated Clinical Implications at the University Teaching Hospital of Kigali in Rwanda. The American Journal of Tropical Medicine and Hygiene. 2024. doi:10.4269/ajtmh.23-0605
BibTeX
@article{Kayinamura2024,
author = {Kayinamura, Muhirwa Patrick and Muhirwa, Alphonse and Kamaliza, Aimee Claudine and Bigirimana, Yves and Rutare, Samuel and Hahirwa, Innocent and Nkubana, Théoneste and Dusabe, Angelique and Munyemana, Jean Bosco},
title = {Prevalence of Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae and Associated Clinical Implications at the University Teaching Hospital of Kigali in Rwanda},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2024},
doi = {10.4269/ajtmh.23-0605}
}
EUVIMED